This Tax Firm Doubled In 2024 And Is A Fund Favorite

Blockhead01-03

A member of the IBD Big Cap 20, Vertex (VERX) is a top stock to consider after impressive growth last year. VERX stock could present an entry point as it pulls back to its 10-week moving average. Not ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2500135904?lang=en_US&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2017/11/Stock-vertex-01-company-150x150.jpg","is_english":true,"pubTime":"2025-01-03 04:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2500135904","market":"fut","top_or_hot":-1,"title":"This Tax Firm Doubled In 2024 And Is A Fund Favorite","media":"Blockhead","content":"<div>\n<p>A member of the IBD Big Cap 20, Vertex (VERX) is a top stock to consider after impressive growth last year. VERX stock could present an entry point as it pulls back to its 10-week moving average.\nNot ...</p>\n\n<a href=\"https://www.investors.com/stock-lists/ibd-big-cap-20/vertex-stock-2024-winning-stock/\">Source Link</a>\n\n</div>\n","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Tax Firm Doubled In 2024 And Is A Fund Favorite</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Tax Firm Doubled In 2024 And Is A Fund Favorite\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-03 04:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/stock-lists/ibd-big-cap-20/vertex-stock-2024-winning-stock/><strong>Blockhead</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A member of the IBD Big Cap 20, Vertex (VERX) is a top stock to consider after impressive growth last year. VERX stock could present an entry point as it pulls back to its 10-week moving average.\nNot ...</p>\n\n<a href=\"https://www.investors.com/stock-lists/ibd-big-cap-20/vertex-stock-2024-winning-stock/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE0009355771.USD","symbol_name":"骏利亨德森环球生命科技A Acc","start_time":0,"source_url":"https://www.investors.com/stock-lists/ibd-big-cap-20/vertex-stock-2024-winning-stock/","article_id":"2500135904","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/11/Stock-vertex-01-company-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2500135904","pubTimestamp":1735848775,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"Vertex plays a crucial role in automating sales and value-added taxes for businesses.","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0079474960.USD":"联博美国增长基金A","LU0566484027.USD":"安本美国小盘成长股","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0058720904.USD":"联博国际健康护理基金A","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","BK4023":"应用软件","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","VERX":"Vertex, Inc.","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","BK4585":"ETF&股票定投概念","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","BK4567":"ESG概念","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","IE00BZ9MQY76.HKD":"FTGF CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (HKD) ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","IE00B894F039.SGD":"Legg Mason ClearBridge - US Aggressive Growth A Acc SGD-H","BK4588":"碎股","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","VRTX":"福泰制药"},"translate_title":"这家税务公司在2024年翻了一番，是基金的最爱","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRTX":1,"VERX":1},"content_text":"A member of the IBD Big Cap 20, Vertex (VERX) is a top stock to consider after impressive growth last year. VERX stock could present an entry point as it pulls back to its 10-week moving average.\nNot to be confused with Vertex Pharmaceuticals (VRTX), Vertex is a company specializing in consulting services and tax preparation software.\n\n\n\n↑\nX\n\n\n\n\nLook For Changes In The Market With These Strategies and Signals\n\n\nSee All Videos\n\n\n\n\nNOW PLAYING\nLook For Changes In The Market With These Strategies and Signals\n\n\n\n\nDespite being somewhat under the radar, the company has a significant reach, providing tax services to 60% of Fortune 500 companies. With 4,300 clients across 190 countries, Vertex plays a crucial role in automating the end-to-end indirect tax processes — such as sales and value-added taxes — for businesses worldwide.\nCloud Revenue Drives Big Earnings Jump\nHaving seen its share price almost double in 2024, Vertex continues to lead IBD's financial software industry group, which ranks 27th out of 197 industries, with the best Composite Rating of 50 companies in the group.\nThe share price surge over the past year has all to do with growth.\nWith only fourth-quarter earnings remaining for 2024 results, the company is expecting its full-year earnings to rise to 61 cents per share, up from 39 cents in 2023.\nCloud revenue is the key driver, with an anticipated 29% year-over-year growth. Total revenue for 2024 is expected to reach $663.3 million, a 16% increase from the previous year.\nOn the company's third-quarter results, Vertex President and CEO David DeStefano noted: \"We are seeing a great deal of excitement from customers about our new comprehensive global cloud platform. ... We believe that the coming wave of e-invoicing regulations, as well as an expected supercycle of ERP (enterprise resource planning) conversions, will be a multiyear tailwind for our business that will drive profitable growth for the foreseeable future.\"\nERP refers to day-to-day business activities such as accounting and supply-chain operations.\nVertex Growth Expected To Slow In 2025\nWhile Vertex's earnings growth has been strong, it is expected to slow down. Analysts expect 2025 earnings at 69 cents per share, for a 13% earnings growth rate. While still positive, it does raise some valuation concerns.\nHowever, some pundits will point to ample room for the company to continue to outperform, especially with the acquisition of Austrian e-invoicing and electronic data interchange company Ecosio, which closed in September.\nInstitutions Bullish On Vertex Stock\n\nInstitutional investors have been actively buying shares. Vertex has a high mutual fund ownership of 64% of shares outstanding, according to IBD MarketSurge. And the number of funds holding the stock has steadily increased, from 238 in June to 397 in December.\nAnalysts are also optimistic about the stock, with a mean price target of 58.42 — an 11% increase from current levels, according to FactSet data.\nVertex stock currently boasts IBD's top Composite Rating of 99.\nAfter reaching an all-time high of 57.74 on Dec. 3, shares have pulled back and are now testing their 10-week moving average. A bounce off that level could provide a potential entry point for investors at around 52.\nIt is the first follow-on buy area since Vertex broke out of a flat base at a 40.05 buy point on Oct. 2.\nYOU MAY ALSO LIKE:\nThe Four Pillars Of The IBD Methodology\nRisk Management In The Stock Market: How Much Money To Invest\nIBD Live: Learn And Analyze Growth Stocks With The Pros","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2500135904"}